# MEA Ischemic Heart Disease Market

> Middle-East and Africa Ischemic Heart Disease Market information, by Type (stable angina, unstable angina, myocardial infarction, and Others), Diagnosis (Electrocardiogram, Echocardiography, Stress Testing, Coronary angiography, Magnetic resonance imaging (MRI), Chest X Ray, and Others), Treatment type (Medications, Surgery, Lifestyle changes, and others) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.5%
- **2023:** $ 1.9 Billion
- **2024:** $ 12.5 Billion
- **2035:** $ 25 Billion
- **Key Players:** Apple Inc (US), Microsoft Corp (US), Amazon.com Inc (US), Alphabet Inc (US), Berkshire Hathaway Inc (US), Tesla Inc (US), Meta Platforms Inc (US), Johnson & Johnson (US), Visa Inc (US), Procter & Gamble Co (US)

**Report ID:** MRFR/MED/1944-HCR · **Pages:** 60 · **Author:** Satyendra Maurya & Rahul Gotadki · **Last Updated:** June 26, 2026

**URL:** https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585

---

## Market Summary

## **Middle-East and Africa Ischemic Heart Disease Market Overview**

Middle-East and Africa Ischemic Heart Disease Market Size was valued at USD 1.90 Billion in 2023. The MEA Ischemic Heart Disease industry is projected to grow from USD 2.30 Billion in 2024 to USD 4.30 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.70% during the forecast period (2024 - 2032).

Ischemic heart disease, also known as Coronary Artery Disease, is a condition that affects the supply of blood to the heart. The blood vessels are narrowed or blocked due to the deposition of cholesterol on their walls. The prevalence of coronary heart disease is promoted in turn by a high prevalence of cardiovascular risk factors, particularly smoking, hypertension, dyslipidemia, diabetes, and sedentary lifestyles. Countries in Middle East and Africa bear a heavy burden from Ischemic heart disease. 

According to, Dubai Health Authority, Heart disease is the cause for every 3 in 10 deaths in the UAE. Huge funding in R&D and various initiatives by government are driving the growth for Ischemic heart Disease market in Middle East and Africa. Middle-East and Africa Ischemic heart Disease market is growing steadily.

**Study objectives of Middle-East and Africa Ischemic Heart Disease Market:**

 **Middle-East and Africa Ischemic Heart Disease Market Segments** 

Middle-East and Africa Ischemic heart Disease market has been segmented on the basis of type which comprise stable angina, unstable angina, myocardial infarction, and Others.  

On the basis of diagnosis the market is segmented into (Electrocardiogram, Echocardiography, Stress Testing, [Coronary angiography](../../../reports/coronary-angiography-devices-market-6151), [Magnetic resonance imaging (MRI)](../../../reports/magnetic-resonance-imaging-systems-market-6194), Chest X Ray, and Others. 

On the basis of treatment type market is segmented into Medications, Surgery, Lifestyle changes, and others. 

## **Key Players for Middle-East and Africa Ischemic Heart Disease Market**

Some of the key players in this market are: 

**Intended Audience:**

## **Regional Analysis of Middle-East and Africa Ischemic heart Disease Market**

Considering the Middle-East and Africa Ischemic heart Disease Market scenario, UAE region is believed to be the largest market for Middle-East and Africa Ischemic heart Disease. Moreover Saudi Arabia market is also growing and second largest market for Ischemic heart disease. On the other hand, Egypt market is expected to grow at the steady pace in the Middle-East and Africa Ischemic heart Disease during the forecasted period. Rest of the Middle East and Africa region is likely to have a limited but steady growth in the market.

The report for Middle-East and Africa Ischemic heart Disease market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry.

The report also gives a broad study of the different markets segments and regions.

## Market Drivers

### Growing Aging Population

The demographic shift towards an aging population in the Middle-East and Africa is a crucial driver for the Global Middle-East and Africa Ischemic Heart Disease Market Industry. Older adults are at a higher risk for developing ischemic heart disease, necessitating increased healthcare services and interventions. As life expectancy rises, the demand for specialized cardiac care is expected to grow. This demographic trend indicates a potential increase in market value, as healthcare systems adapt to meet the needs of an aging population.

### Market Growth Projections

The Global Middle-East and Africa Ischemic Heart Disease Market Industry is projected to witness substantial growth, with estimates suggesting a market value of 12.5 USD Billion in 2024 and a potential increase to 25 USD Billion by 2035. This growth trajectory indicates a compound annual growth rate (CAGR) of 6.5% from 2025 to 2035. Such projections reflect the increasing demand for innovative treatments and healthcare solutions in response to the rising prevalence of ischemic heart disease in the region.

### Increased Awareness and Education

Rising awareness and education regarding ischemic heart disease are pivotal in shaping the Global Middle-East and Africa Ischemic Heart Disease Market Industry. Health organizations and NGOs are actively promoting knowledge about risk factors, symptoms, and preventive measures. This heightened awareness encourages individuals to seek medical attention earlier, leading to improved health outcomes. Consequently, the demand for diagnostic and therapeutic solutions is likely to rise, further propelling market growth in the coming years.

### Advancements in Medical Technology

Technological innovations in the medical field are transforming the Global Middle-East and Africa Ischemic Heart Disease Market Industry. The introduction of advanced diagnostic tools, minimally invasive surgical techniques, and novel therapeutic agents enhances patient outcomes and treatment efficiency. For example, the adoption of telemedicine and remote monitoring systems allows for better management of ischemic heart disease, particularly in remote areas. These advancements not only improve patient care but also stimulate market growth, with projections indicating a market value of 25 USD Billion by 2035.

### Rising Prevalence of Ischemic Heart Disease

The Global Middle-East and Africa Ischemic Heart Disease Market Industry is experiencing growth due to the increasing prevalence of ischemic heart disease across the region. Factors such as urbanization, sedentary lifestyles, and dietary changes contribute to the rising incidence of this condition. For instance, the World Health Organization indicates that cardiovascular diseases are responsible for a significant portion of mortality in the Middle-East and Africa. This trend suggests a growing demand for effective treatment options and healthcare services, potentially driving the market value to 12.5 USD Billion in 2024.

### Government Initiatives and Healthcare Policies

Government initiatives aimed at combating ischemic heart disease significantly influence the Global Middle-East and Africa Ischemic Heart Disease Market Industry. Various countries are implementing healthcare policies that focus on prevention, early diagnosis, and treatment of cardiovascular diseases. For instance, public health campaigns promoting healthy lifestyles and regular screenings are becoming more prevalent. These initiatives are likely to enhance awareness and accessibility to healthcare services, thereby driving market growth at a CAGR of 6.5% from 2025 to 2035.

## Future Outlook

The Middle-East and Africa Ischemic Heart Disease Market is projected to grow at a 6.5% CAGR from 2025 to 2035, driven by increasing prevalence, technological advancements, and enhanced healthcare access.

**New opportunities:**

- Invest in telehealth solutions to improve patient monitoring and management. Develop innovative [drug delivery systems](https://www.marketresearchfuture.com/reports/drug-delivery-system-market-43638) targeting ischemic heart disease. Expand partnerships with local healthcare providers to enhance service delivery and reach.

By 2035, the market is expected to exhibit robust growth, reflecting advancements in treatment and increased healthcare investments.

## Report Scope

| Attribute/Metric | Details |
| --- | --- |
| Market Size 2023 | 1.9 (USD Billion) |
| Market Size 2024 | 2.3 (USD Billion) |
| Market Size 2032 | 4.3 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 6.7 % (2024 - 2032) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2023 |
| Market Forecast Period | 2024 - 2032 |
| Historical Data | 2019 - 2023 |
| Geographies Covered | Middle East & Africa |
|   Key Vendors | King Faisal Specialist Hospital and Research Centre (Saudi Arabia), Riyadh Military Hospital (Saudi Arabia), Hamad Medical Corporation (Qatar), American Hospital Dubai, Ganzouri Specialized Hospital (Egypt), AstraZeneca (U.K.), Sanofi (France), Merck Sharp & Dohme Corp. (U.S.), AUM Cardiovascular (US), HeartWare (U.S.). |
| Key Market Opportunities | Joint ventures, strategic alliances, mergers, acquisitions and new product developments |
| Key Market Drivers | Huge funding in R&D and various initiatives by government |

---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/mea-ischemic-heart-disease-market-2585*